PET scans for brain and head/neck tumors
Part of Brain & nervous system, Cancer clinical trials.
This study gives patients access to a special type of PET scan that can help doctors see brain and head/neck tumors more clearly. The scan uses a radioactive tracer called methionine, which may help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated by a doctor at St. Jude Children's Research Hospital.
- You have a known or suspected tumor in the brain, head, or neck.
- You have not had more than six of these special PET scans in the past year.
- If you are a woman who could become pregnant, you must not be breastfeeding.
- You or your guardian must agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a combined PET/MR scan to better look at head and neck squamous cell cancer before or during treatment. It may help doctors see where the cancer is and how far it has spread, to support planning for curative radiation treatment.
This trial tests a new PET scan tracer to see inflammation in brain tumors that have not been treated with radiation. It may help doctors better understand and monitor these tumors.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This trial uses a special PET scan tracer called 18F-FMISO to see areas of low oxygen (hypoxia) in your tumor. The results may help doctors adjust your radiation plan to target those areas more precisely.
This study tests a special PET/CT scan that may help doctors see the cancer more clearly in people with head and neck cancer, either at diagnosis or if it comes back.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
Hear when a new Central Nervous System Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.